enGene Holdings Inc. Warrants logo ENGNW - enGene Holdings Inc. Warrants

Price: -- --
Metric 2025 2024 2023 2022 2021 2020
Revenue
Revenue 0 0 0 0 0 0
Cost of Revenue 0 0 0 0 0 0
Gross Profit 0 0 0 0 0 0
Operating Expenses
R&D Expenses 94.5 38.3 16.5 15.5 12.5 10.6
SG&A Expenses 28.7 24.0 8.5 3.3 3.2 3.2
Other Expenses 0 0 1.1 0.7 0.3 0.6
Operating Expenses 123.2 62.3 26.1 19.4 15.9 13.9
Operating Income
Operating Income (123.2) (62.3) (26.1) (19.4) (15.9) (13.9)
Interest Expense 3.0 2.8 5.0 1.4 5.0 3.7
Interest Income 9.4 10.4 1.1 0.1 0.0 0.1
Profitability
EBITDA (113.8) (52.0) (94.8) (22.8) (18.1) (12.9)
EBIT (114.3) (52.4) (94.9) (23.0) (18.4) 0
Income Before Tax (117.3) (55.2) (99.9) (24.4) (23.4) (15.1)
Income Tax Expense 0 (0.0) 0.0 0.0 0 0
Net Income (117.3) (55.1) (99.9) (24.5) (23.4) (15.1)
Per Share Data
EPS (Basic) -2.29 -1.46 -4.24 0.00 -0.01 -0.95
EPS (Diluted) -2.29 -1.46 -4.24 0.00 -0.01 -0.95
Shares Outstanding 51.1 44.6 23.6 15.8 15.8 15.8
Metric 2025 2024 2023 2022 2021
Current Assets
Cash & Cash Equivalents 50.2 173.0 81.5 0.3 1.1
Short-Term Investments 143.7 65.4 0.1 0 0
Net Receivables 2.2 1.0 2.3 0 0
Inventory 0 0 0 0 0
Other Current Assets 5.3 7.9 1.5 0 0
Total Current Assets 201.4 247.4 85.4 0.5 1.6
Non-Current Assets
Property, Plant & Equipment 10.2 2.9 0.6 0 0
Goodwill 0 0 0 0 0
Intangible Assets 0 0 0 0 0
Long-Term Investments 8.5 59.5 0.1 131.5 129.7
Other Non-Current Assets 1.4 1.4 0.9 0 0.2
Total Non-Current Assets 20.1 63.8 1.5 131.5 129.9
Total Assets 221.5 311.2 87.0 132.0 131.4
Current Liabilities
Account Payables 6.7 1.4 1.2 0 0
Short-Term Debt 10.0 1.1 0.6 0 0
Deferred Revenue 0 0 0 0 0
Other Current Liabilities 11.2 8.7 2.7 0.9 0.3
Total Current Liabilities 32.0 14.7 5.3 0.9 0.3
Non-Current Liabilities
Long-Term Debt 15.3 22.5 9.2 0 0
Deferred Tax Liabilities 0 0 0 0 0
Other Non-Current Liabilities 0 0 0 3.7 0
Total Non-Current Liabilities 21.8 23.9 9.2 3.7 3.7
Total Liabilities 53.8 38.6 14.5 4.6 4.1
Stockholders' Equity
Common Stock 513.3 509.8 259.4 131.5 129.7
Retained Earnings (372.0) (254.7) (199.6) (4.1) (2.3)
Accumulated Other Comprehensive Income (0.9) (1.4) (1.0) 0 0
Total Stockholders' Equity 167.7 272.6 72.5 127.4 127.4
Total Liabilities & Equity 221.5 311.2 87.0 132.0 131.4
Debt Metrics
Total Debt 31.8 25.0 9.8 0 0
Net Debt (18.4) (148.0) (71.7) (0.3) (1.1)
Metric 2025 2024 2023 2022 2021 2020
Operating Activities
Net Income (117.3) (55.1) (99.9) (24.5) (23.4) (15.1)
Depreciation & Amortization 0.5 0.3 0.2 0.2 0.3 0.3
Stock-Based Compensation 9.6 5.3 3.5 0.1 0.4 0.1
Change in Working Capital 9.7 0.1 (0.5) 2.2 (1.0) 0.4
Other Non-Cash Items (1.8) 1.1 72.1 4.3 7.8 1.2
Operating Cash Flow (99.2) (48.3) (24.7) (17.6) (16.0) (13.1)
Investing Activities
Capital Expenditure (1.5) (0.9) (0.3) (0.2) (0.2) (0.2)
Acquisitions 0 0 0 0 0 0
Purchases of Investments (160.8) (125.0) 0 0 0 0
Sales/Maturities of Investments 137.2 0 0 0 0 0
Other Investing Activities 0 0 0 0 0.0 0
Investing Cash Flow (25.1) (126.0) (0.3) (0.2) (0.2) (0.2)
Financing Activities
Net Debt Issuance (0.7) 13.1 33.3 28.4 7.1 13.0
Stock Repurchased 0 0 0 0 0 0
Dividends Paid 0 0 0 0 0 0
Other Financing Activities 0 (7.5) (4.0) (0.4) (0.1) (0.2)
Financing Cash Flow 1.5 265.7 86.1 28.0 22.5 12.8
Cash Position
Net Change in Cash (122.9) 91.5 61.1 9.4 6.4 (0.5)
Cash at Beginning 173.0 81.5 20.4 11.0 4.6 5.1
Cash at End 50.2 173.0 81.5 20.4 11.0 4.6
Free Cash Flow (100.7) (49.2) (25.1) (17.7) (16.2) (13.3)
Key Metrics 2025 2024 2023 2022 2021 2020
Income Statement
Revenue 0 0 0 0 0 0
Gross Profit 0 0 0 0 0 0
Operating Income (123.2) (62.3) (26.1) (19.4) (15.9) (13.9)
Net Income (117.3) (55.1) (99.9) (24.5) (23.4) (15.1)
EPS (Diluted) -2.29 -1.46 -4.24 0.00 -0.01 -0.95
Balance Sheet
Cash & Equivalents 50.2 173.0 81.5 0.3 1.1
Total Assets 221.5 311.2 87.0 132.0 131.4
Total Debt 31.8 25.0 9.8 0 0
Stockholders' Equity 167.7 272.6 72.5 127.4 127.4
Cash Flow
Operating Cash Flow (99.2) (48.3) (24.7) (17.6) (16.0) (13.1)
Capital Expenditure (1.5) (0.9) (0.3) (0.2) (0.2) (0.2)
Free Cash Flow (100.7) (49.2) (25.1) (17.7) (16.2) (13.3)